VAXX stock at $0.0001 intraday on 11 Feb 2026: critical risks for NASDAQ holders

VAXX stock dropped to $0.0001 intraday on 11 Feb 2026, an intraday fall of -99.42% from yesterday’s close. Trading volume was 452 shares versus a 50-day average of 16,969, and market capitalization sits at $2,187,036.00 USD on the NASDAQ in the United States. The move follows thin liquidity and continued negative fundamentals, with trailing EPS at -0.45 and a negative PE metric. We examine price drivers, clinical and balance-sheet context, and technicals for active traders and long-term investors.